Volitionrx (VNRX) Debt to Equity (2019 - 2025)
Volitionrx (VNRX) has disclosed Debt to Equity for 8 consecutive years, with -$0.16 as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Debt to Equity rose 22.83% year-over-year to -$0.16, compared with a TTM value of -$0.16 through Sep 2025, up 22.83%, and an annual FY2024 reading of -$0.15, up 72.7% over the prior year.
- Debt to Equity was -$0.16 for Q3 2025 at Volitionrx, up from -$0.21 in the prior quarter.
- Across five years, Debt to Equity topped out at $1.18 in Q3 2022 and bottomed at -$1.23 in Q1 2023.
- Average Debt to Equity over 5 years is -$0.13, with a median of -$0.18 recorded in 2025.
- Peak annual rise in Debt to Equity hit 793.65% in 2022, while the deepest fall reached 810.32% in 2022.
- Year by year, Debt to Equity stood at $0.17 in 2021, then tumbled by 810.32% to -$1.23 in 2022, then skyrocketed by 54.91% to -$0.55 in 2023, then soared by 72.7% to -$0.15 in 2024, then dropped by 8.12% to -$0.16 in 2025.
- Business Quant data shows Debt to Equity for VNRX at -$0.16 in Q3 2025, -$0.21 in Q2 2025, and -$0.22 in Q1 2025.